Table 3.
Details of patients whose overall treatment times were >63 days
| No. | Age (years) | FIGO stage | Tumor size (cm) | Histology | OTT (days) | EQD2 HR-CTV D90 (Gy) | Concurrent chemotherapy | Reason for delay | Outcome |
|---|---|---|---|---|---|---|---|---|---|
| 1. | 86 | IIB | 3.9 | SCC | 77 | 77.0 | None | 1 Month delay due to dislocation of artificial femoral head | Local recurrence 19 months |
| 2. | 62 | IIIb | 5.7 | SCC | 64 | 86.3 | wNDP*4 | National holiday poor general condition | Alive 40 months |
| 3. | 43 | IIIa | 6.5 | SCC | 64 | 58.1 | wNDP*6 | 1 Week delay due to Tandem perforation at 1st RALS | Pelvic LN rec 12 months |
| 4. | 56 | IIIb | 5.6 | SCC | 83 | 60.2 | wNDP*5 | 1 Month delay due to ileus from fallopian tube abscess | Local recurrence 4 months |
| 5. | 72 | IIIb | 7.1 | SCC | 65 | 74.2 | wNDP*4 | 1 Week delay from EBRT to ICBT and national holiday | Alive 64 months |
| 6. | 52 | IIIb | 4.3 | SCC | 68 | 66.7 | wCDDP*3 | 3 Week delay due to grade 3 leukocytepenia | Distant metastasis 6 months |
wNDP*4,5,6 = 4, 5, or 6 cycles of weekly nedaplatin administration, LN rec = lymph node recurrence, wCDDP*3 = 3 cycles of weekly Cisplatin administration.